pfizer辉瑞品牌怎么样 申请店铺

我要投票 pfizer辉瑞在中草药行业中的票数:627 更新时间:2025-03-11
pfizer辉瑞是哪个国家的品牌?「pfizer辉瑞」是 辉瑞投资有限公司 旗下著名品牌。该品牌发源于上海,由创始人苗天祥在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力pfizer辉瑞品牌出海!通过在本页面挂载pfizer辉瑞品牌的产品链接和联系邮箱,可以提高pfizer辉瑞产品曝光!跨境电商爆单神器,目前只要100元/年哦~

pfizer辉瑞怎么样

辉瑞公司创建于1849年,迄今已有160多年的历史,总部位于美国纽约,是目前全球最大的以研发为基础的生物制药公司之一。

辉瑞生物制药在华上市的创新药物已超过50个,其治疗领域涵盖了心脑血管及代谢、抗感染、中枢神经、抗炎镇痛、抗肿瘤、泌尿、血液健康(包括血友病)等诸多领域。其中如立普妥®、络活喜®、万艾可®、舒普深®、大扶康®、希舒美®、索坦®、开普拓®、阿诺新®、任捷®、贝赋®等许多产品在市场上处于领先地位。为了让中国的广大患者能及时接受与全球同步的先进的药物治疗,辉瑞未来将进一步加大和加快在华新药引进和上市的力度和速度。

辉瑞健康药物旗下的善存®、钙尔奇®、惠菲宁®等消费保健产品也在中国市场家喻户晓,并以其优异的品质深受广大消费者的青睐。

自20世纪80年代进入中国以来,辉瑞目前已发展成为在华大型外资制药企业。辉瑞在中国有约10000多名员工,业务覆盖了全国250余个城市。辉瑞始终把“携手共创健康中国”作为在华的使命,承诺并积极参与促进中国医疗卫生事业的发展和提高人民健康水平。我们志在通过创新的、富有社会责任并且商业可行的方式,满足中国13亿人民多样化的医疗服务需求。除了提供广泛的创新医药健康产品组合外,辉瑞还积极与有关政府部门、科研/医疗机构、学术组织、社会团体等各方面合作,通过开展患者教育、疾病宣传、健康管理、社区医疗、人才培养等项目积极推动中国医疗卫生事业的发展。

Founded in 1849, Pfizer has a history of more than 160 years. Headquartered in New York, the company is one of the largest R & D-based biopharmaceutical companies in the world. Pfizer biopharmaceuticals has been listed in more than 50 innovative drugs in China, and its treatment fields cover cardio cerebrovascular and metabolism, anti infection, central nervous system, anti-inflammatory and analgesic, anti-tumor, urinary, blood health (including hemophilia) and many other fields. Among them, many products, such as Lipitor ®, luohuoxi ®, Viacom ®, shupushen ®, Dafukang ®, sisumi ®, sotan ®, keputuo ®, anoxin ®, Renjie ®, Beifu ®, are in the leading position in the market. In order to enable the vast number of patients in China to receive advanced drug treatment in time with the global synchronization, Pfizer will further increase and speed up the introduction and marketing of new drugs in China in the future. Pfizer's consumer health care products, such as Shancun ®, Caltech ®, and huifeining ®, are also well known in the Chinese market, and are favored by the majority of consumers with their excellent quality. Since entering China in 1980s, Pfizer has developed into a large foreign pharmaceutical enterprise in China. Pfizer has more than 10000 employees in China, covering more than 250 cities across the country. Pfizer has always taken "working together to create a healthy China" as its mission in China, committed to and actively participated in promoting the development of China's medical and health undertakings and improving the people's health level. We aim to meet the diverse needs of China's 1.3 billion people through innovative, socially responsible and commercially viable ways. In addition to providing a wide range of innovative pharmaceutical and health product portfolio, Pfizer also actively cooperates with relevant government departments, scientific research / medical institutions, academic organizations, social organizations and other aspects, and actively promotes the development of China's medical and health undertakings through patient education, disease publicity, health management, community medical care, talent training and other projects.

本文链接: https://brand.waitui.com/9f250b20b.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

我国科学家在抗烧结催化剂研究中取得新进展

36氪获悉,据中国科学技术大学消息,该校曾杰教授团队通过构筑纳米岛结构催化剂,攻克了甲烷干重整反应中催化剂极易烧结失活的难题。相关研究成果3月10日发表于国际学术期刊《自然∙材料》。超细金属纳米颗粒因其超高的原子利用率,在多相催化领域备受青睐。然而,在催化反应过程中,这些纳米颗粒极易受到高温等影响,从而自发聚集并导致活性降低,该过程被称作烧结。发展超细金属纳米颗粒的抗烧结策略,是催化科学领域亟待解决的关键难题。

2小时前

蔚蓝锂芯:2024年净利润4.88亿元,同比增长246.43%

36氪获悉,蔚蓝锂芯公告,公司实现营业总收入67.56亿元,同比增长29.38%;实现净利润5.44亿元,同比增长171.98%;归属于上市公司股东的净利润4.88亿元,同比增长246.43%。公司拟以2024年12月31日总股本1,152,046,537股为基数,向全体股东每10股派发现金红利0.65元(含税)。

2小时前

美股大型科技股盘前全线下跌,特斯拉跌超3%

36氪获悉,美股大型科技股盘前全线下跌,截至发稿,特斯拉、Arm跌超3%,英伟达、亚马逊、谷歌、Meta跌超2%,苹果、微软、奈飞跌超1%。

2小时前

热门中概股美股盘前普跌,B站跌超4%

36氪获悉,热门中概股美股盘前普跌,截至发稿,B站跌超4%,阿里巴巴跌超3%,京东、爱奇艺、腾讯音乐、蔚来、理想汽车、小鹏汽车跌超2%,拼多多、百度跌超1%。

2小时前

新产业:红杉聚业拟减持不超1%公司股份

36氪获悉,新产业公告,公司持股5%以上的股东天津红杉聚业股权投资合伙企业(有限合伙)计划自公告之日起15个交易日后的3个月内通过大宗交易方式减持公司股份不超过总股本的1%。若公司在减持计划实施期间发生送股、资本公积转增股本、配股等变动事项,减持股份数量进行相应调整。减持原因为自身资金需求。

2小时前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询